BRAINBox Solutions Expands Patent Portfolio Covering Diagnostic & Prognostic Technology For Concussion & Neurodegenerative Disease Tests

BRAINBox Solutions has received three additional U.S. patents, expanding its intellectual property portfolio around technologies for diagnosing and monitoring concussion—also referred to as mild traumatic brain injury—and neurodegenerative diseases.

BRAINBox Solutions is developing a diagnostic platform for concussion that combines blood-based biomarkers, neurocognitive testing, and AI analysis into a single system. The biomarker panel is designed to be read rapidly using point-of-care instruments or standard laboratory equipment. Together, these inputs generate a score intended to reflect injury severity and post-concussive symptoms, with the goal of informing clinical decision-making and guiding treatment.

The . . .